
Kytib 1mg Tablet
Marketer
Hetero Drugs Ltd
Salt Composition
Axitinib (1mg)
Overview Kytib 1mg Tablet
Onureg (1mg tablet) is an anticancer medication indicated for renal cell carcinoma. Administer Onureg once daily, with or without food, for optimal therapeutic response. Dosage and frequency are determined by your physician, depending on your individual needs and may be adjusted. Adhere strictly to your prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for several weeks or months; discontinue only under your doctor's instruction. Common side effects include hypertension, arthralgia, and anorexia. While diarrhea and dyspnea can sometimes be serious, promptly address these with prescribed medication or adequate hydration. Regular blood pressure monitoring is typically recommended. Report severe headache, cognitive impairment, visual disturbances, nausea, or emesis immediately. Prior to commencement, disclose any thyroid conditions, hepatic dysfunction, bleeding disorders, or concomitant use of antimicrobial agents. Numerous drug interactions are possible; inform your healthcare provider of all medications. Onureg is contraindicated during gestation and lactation. Effective contraception is crucial for women undergoing treatment to prevent pregnancy.
Uses of Kytib 1mg Tablet
Renal cell carcinoma
Major Benefits of Kytib 1mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Kytib 1mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Kytib 1mg Tablet:
- High blood pressure
- Joint pain
- Loss of appetite
- Diarrhea
- Breathing problems
- Abdominal pain
- Constipation
- Cough
- Decreased appetite
- Decreased level of thyroid hormones
- Difficulty in speaking
- Dry skin
- Indigestion
- Headache
- Nausea
- Pain in extremities
- Painful blisters on hands and feet
- Protein in urine
- Rash
- Breathlessness
- Stomatitis (Inflammation of the mouth)
- Taste change
- Vomiting
How to use Kytib 1mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Kytib 1mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Kytib 1mg Tablet works:
Kytib 1mg tablets are an anticancer drug. Their mechanism involves inhibiting a protein responsible for signaling cancerous cell proliferation, thus hindering or slowing tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Kytib 1mg Tablet may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Kytib 1mg Tablet is contraindicated during pregnancy due to confirmed risk to the fetus. Exceptions may be made in life-threatening circumstances where the potential benefits outweigh the known hazards, as determined by a physician. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding mothers should likely avoid Kytib 1mg Tablets. Studies in humans indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Kytib 1mg tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving is inadvisable if these effects are experienced.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Kytib 1mg tablets are considered safe. No alteration to the Kytib 1mg tablet dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Kytib 1mg tablets cautiously, potentially requiring dosage modification. Seek medical advice before using this medication. Data regarding Kytib 1mg tablet use in patients with severe hepatic dysfunction is limited.
What if you forget to take Kytib 1mg Tablet :
NA
Facts to Know About Kytib 1mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Indazole and Enzamide Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | TKIs (Tyrosine Kinase Inhibitors) |
